FDA warned Binh Minh Tofu that its ready-to-eat tofu was adulterated after a March 2026 inspection found unsafe cooling, sanitation and hygiene failures.
What happened
FDA inspected the San Jose facility from March 2 through March 6, 2026 and found serious CGMP (current good manufacturing practice) violations for ready-to-eat tofu, including inadequate cooling, contamination during cleaning and sanitizing, poor glove and jewelry practices, equipment with cracks and a cleaning dead spot, and floors and walls in disrepair. The agency also found labeling violations, including undeclared artificial flavor and colors, misleading "fresh" claims, and incomplete Nutrition Facts and ingredient information. The company responded on March 21, 2026, but FDA said key corrective actions were not scientifically supported or not shown to be implemented.
What FDA found
The company did not have adequate controls to cool cooked ready-to-eat tofu quickly enough to prevent growth of pathogens such as Bacillus cereus and Clostridium perfringens.
21 CFR 117.80(c)(2)Employees cleaned and sanitized tofu molds, bins, and other food-contact equipment in ways that allowed splash-back and debris to contaminate them, and sanitizer strength was not maintained.
21 CFR 117.35(a), (d)Employees touched dirty surfaces and then handled ready-to-eat tofu or gloves without proper handwashing or glove changes, and one employee wore bracelets that touched the tofu.
21 CFR 117.10(b)Equipment was not cleanable or maintained: a soymilk pipe had a section that cleaning water might not reach, and utensils and molds had cracks or rough welds.
21 CFR 117.40(a)The building was not kept clean and in repair, with worn floors holding standing water, wall gaps and holes, decaying doorframes, and peeling paint over a packaging table.
21 CFR 117.35(a)Product labels were misbranded: they did not declare artificial flavor and colors, called processed tofu "fresh," and had incomplete Nutrition Facts, ingredient, serving-size, and bilingual information.
21 U.S.C. § 343(k), (a)(1), (q), (f), (i)(2), (i)(1); 21 CFR Part 101
What FDA wants
FDA asks the company to investigate and determine the causes of the violations, prevent recurrence, and correct the findings; the letter excerpt does not state a response deadline and says failure to adequately address the matter may lead to legal action.
Who should pay attention
- tofu and soy food manufacturers
- retailers and distributors selling ready-to-eat refrigerated foods
- food safety and quality teams at ready-to-eat food plants
This is a summary. Read the original letter on fda.gov.